Corsair Gaming Inc vs Edwards Lifesciences Corporation Common Stock — how do they compare? Corsair Gaming Inc trades at $13.28 (market cap $1.42B), while Edwards Lifesciences Corporation Common Stock trades at $83.6 (market cap $48.56B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 34.2× Corsair Gaming Inc's market cap, and Corsair Gaming Inc is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| CRSR | EW | |
|---|---|---|
Market Cap | $1.42B | $48.56B |
Volume | 1,160,938 | 6,520,488 |
Sector | Technology | Health |
52-Week High | $14.35 | $95.18 |
52-Week Low | $4.58 | $72.65 |
Typical Hold Time | 25 Days | — |
Enterprise Value | $1.41B | $45.01B |
Signals from Pluang's Aura AI — not financial advice
CRSR trades at $13.1, down 3.61% today, with a bullish technical signal from moving averages and a neutral RSI. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $0.23 versus $0.07 expected. The company reported a net loss of $16.16 million in 2025 but forecasts a profit of $37 million for 2026. Positive developments include new product launches like the VOXARA microphone and strategic acquisitions such as Trak Racer assets.
The outlook is mixed; strong earnings beats and product innovation support growth, but high P/E of 42.23 and recent net losses pose valuation and profitability risks. Analyst consensus is a 'Hold' with a $12.40 price target, slightly below the current price, indicating cautious optimism amid execution challenges.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Read more on CRSR →Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →